Source https://www.fightaging.org/archives/2025/07/a-conservative-view-of-rapamycin/
The dominant view of the regulation of medicine within academia and government is more or less that (a) people should not have the right to choose their own risks and make their own mistakes, (b) the role of regulators is to remove as much risk as possible, and (c) that the high cost of medicine and slow pace of introduction of new drugs is a better problem to have than greater freedom for patients. This is the background against which one can find papers such as today’s open access discussion of rapamycin and the state of its use as a means to improve late life health and modestly slow degenerative aging.
Rapamycin has long been approved for use as an immunosuppressive drug, but of late has attracted far more attention for its ability to upregulate autophagy, slow aging, and extend life in ani…
Source https://www.fightaging.org/archives/2025/07/a-conservative-view-of-rapamycin/
The dominant view of the regulation of medicine within academia and government is more or less that (a) people should not have the right to choose their own risks and make their own mistakes, (b) the role of regulators is to remove as much risk as possible, and (c) that the high cost of medicine and slow pace of introduction of new drugs is a better problem to have than greater freedom for patients. This is the background against which one can find papers such as today’s open access discussion of rapamycin and the state of its use as a means to improve late life health and modestly slow degenerative aging.
Rapamycin has long been approved for use as an immunosuppressive drug, but of late has attracted far more attention for its ability to upregulate autophagy, slow aging, and extend life in ani…
What Do You Think?
comments